Kinderhook, NY, United States of America

Rob Bernstine


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rob Bernstine: Innovator in Lateral Flow Immunoassay Testing

Introduction

Rob Bernstine is an accomplished inventor based in Kinderhook, NY (US). He has made significant contributions to the field of biomedical testing, particularly through his innovative patent related to lateral flow immunoassay systems. His work has the potential to enhance diagnostic testing methods, making them more efficient and accessible.

Latest Patents

Rob Bernstine holds a patent for a "System and method for lateral flow immunoassay testing." This invention features a housing with a base portion that forms a first chamber, along with a body portion that includes three openings in fluid communication with the first chamber. The system incorporates a vial containing a buffer agent and a sample collector for introducing a sample fluid into the first chamber. The design allows for the mixing of the buffer agent and sample fluid within a reaction well, facilitating the creation of a test sample mixture. The body portion is also configured to accommodate an elongated holder that brings a test strip into contact with the test sample mixture.

Career Highlights

Rob Bernstine is associated with American Bio Medica Corporation, where he applies his expertise in developing innovative biomedical solutions. His work at the company reflects his commitment to advancing medical technology and improving patient outcomes.

Collaborations

Throughout his career, Rob has collaborated with notable colleagues, including Douglas Casterlin and Larry Ferringo. These partnerships have contributed to the development and refinement of his innovative ideas.

Conclusion

Rob Bernstine's contributions to the field of lateral flow immunoassay testing exemplify the impact of innovation in biomedical technology. His patent and work at American Bio Medica Corporation highlight his dedication to improving diagnostic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…